HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Market Research In Brief

This article was originally published in The Rose Sheet

Executive Summary

Eye makeup driving cosmetics sales: Eye makeup sales have risen 38% since 2004, compared with 11% increase in overall color cosmetics market, according to Mintel's July 7 release. The market intelligence firm says 65% of survey respondents reported using mascara, which is "one of the fastest-growing segments in color cosmetics." Senior Beauty Analyst Kat Fay offers insight: "The focus is now on more dramatic eyes. ... Mascara products are offering everything from serums to invigorate your natural lashes to iridescent particles that reflect light to bring out a woman's natural eye color." Markwins aims to undercut the competition with a $6.99 eyelash-growth serum launching in January 2011 from its wet n wild brand (1"The Rose Sheet" June 21, 2010). Revlon's Almay intense i-color products award "enhanced eye color" with firm's "light interplay technology" (2"The Rose Sheet" April 5, 2010, Marketing In Brief). Mintel says women are donning mascara five times a week. Meanwhile, 63% and 62% of women are using eyeshadow and eyeliner, respectively, firm notes. The most popular color cosmetics are still lipstick and lipgloss, with 76% of women using the products, reportedly. However, Euromonitor research suggests consumers have been making do with products they already have, rather than buying new ones, which explains the category's modest growth (3"The Rose Sheet" July 5, 2010)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel